Boston Scientific Corporation (ETR:BSX)
84.20
+1.80 (2.18%)
At close: Apr 17, 2025, 5:30 PM CET
Boston Scientific Revenue
Boston Scientific had revenue of $4.66B USD in the quarter ending March 31, 2025, with 20.93% growth. This brings the company's revenue in the last twelve months to $17.55B, up 19.36% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$17.55B
Revenue Growth
+19.36%
P/S Ratio
7.92
Revenue / Employee
$331.21K
Employees
53,000
Market Cap
128.71B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 34.18B |
Deutsche Telekom AG | 118.43B |
Siemens Aktiengesellschaft | 76.54B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 9.75B |
Deutsche Börse AG | 5.80B |
Merck KGaA | 21.16B |
Boston Scientific News
- 20 days ago - Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha
- 20 days ago - Price Over Earnings Overview: Boston Scientific - Benzinga
- 22 days ago - Goldman Sachs Thinks These Stocks Are ‘Insulated' From a Trade War - Barrons
- 22 days ago - Boston Scientific announces conference call discussing first quarter 2025 results - PRNewsWire
- 27 days ago - $100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today - Benzinga
- 4 weeks ago - Medical Products Leader Tops These Early-Bird Buy Points - Investor's Business Daily
- 5 weeks ago - Boston Scientific: Bright Future, Rather Pricey - Seeking Alpha
- 7 weeks ago - Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript) - Seeking Alpha